Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | LMNA | P02545 | 2/20 | 0.47 |
| ▸ | MTNR1A | P48039 | 1/20 | 0.46 |
| ▸ | MTNR1B | P49286 | 1/20 | 0.46 |
| ▸ | GAA | P10253 | 2/20 | 0.46 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.46 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.46 |
| ▸ | PKM | P14618 | 1/20 | 0.46 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.46 |
| ▸ | POLB | P06746 | 1/20 | 0.42 |
| ▸ | KMT2A | Q03164 | 3/20 | 0.42 |
| ▸ | MEN1 | O00255 | 2/20 | 0.42 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.42 |
| ▸ | TP53 | P04637 | 1/20 | 0.42 |
| ▸ | HPGD | P15428 | 1/20 | 0.42 |
| ▸ | RXFP1 | Q9HBX9 | 1/20 | 0.40 |
| ▸ | ANPEP | P15144 | 1/20 | 0.40 |
| ▸ | LAP3 | P28838 | 1/20 | 0.40 |
| ▸ | PARP10 | Q53GL7 | 1/20 | 0.39 |
| ▸ | TSHR | P16473 | 2/20 | 0.39 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.39 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL15709 | 0.93 | LMNA (0.52) | LMNAMTNR1AMTNR1BGAACYP1A2 | |
| SCHEMBL167127 | 0.93 | LMNA (0.52) | LMNAMTNR1AMTNR1BGAACYP1A2 | |
| Benzene SCHEMBL28097669 | 0.93 | LMNA (0.52) | LMNAMTNR1AMTNR1BGAACYP1A2 | |
| SCHEMBL28824443 | 0.91 | LMNA (0.50) | LMNAMTNR1AMTNR1BGAACYP1A2 | |
| Hydrochloric Acid SCHEMBL12613519 | 0.91 | LMNA (0.50) | LMNAMTNR1AMTNR1BGAACYP1A2 | |
| SCHEMBL14880143 | 0.91 | LMNA (0.50) | LMNAMTNR1AMTNR1BGAACYP1A2 | |
| Methyl Alcohol SCHEMBL7078021 | 0.91 | LMNA (0.50) | LMNAMTNR1AMTNR1BGAACYP1A2 | |
| SCHEMBL21803703 | 0.91 | LMNA (0.50) | LMNAMTNR1AMTNR1BGAACYP1A2 | |
| Hydrochloric Acid SCHEMBL11909844 | 0.91 | LMNA (0.50) | LMNAMTNR1AMTNR1BGAACYP1A2 | |
| Water SCHEMBL30489926 | 0.91 | LMNA (0.50) | LMNAMTNR1AMTNR1BGAACYP1A2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-8029798-B2 | Multivalent vaccine composition with mixed carrier | SANOFI PASTEUR S.A. (FR) | 2011-10-04 | — | — | US | disclosed |
| US-20110117123-A1 | Multivalent Vaccine Composition With Mixed Carrier | SANOFI PASTEUR S.A. (FR) | 2011-05-19 | — | — | US | disclosed |
| US-7862823-B1 | Multivalent vaccine composition with mixed carrier | SANOFI PASTEUR S.A. (FR) | 2011-01-04 | — | — | US | disclosed |
| US-7812006-B2 | Conjugates obtained by reductive amination of the pneumococcus serotype 5 capsular polysaccharide | AVENTIS PASTEUR S.A. (FR) | 2010-10-12 | — | — | US | disclosed |
| US-20040170638-A1 | Conjugates obtained by reductive amination of the pneumococcus serotype 5 capsular polysaccharide | AVENTIS PASTEUR, S.A. | 2004-09-02 | — | — | US | disclosed |
| US-20030099672-A1 | Pneumococcus polysaccharide conjugates for use as vaccine against tetanus an diphtheria | AVENTIS PASTEUR S.A. (FR) | 2003-05-29 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20040170638-A1 | Conjugates obtained by reductive amination of the pneumococcus serotype 5 capsular polysaccharide | FUT5, B3GNT2, CSGALNACT1 | LMNA 2014/4885MTNR1A 1172/4885MTNR1B 1178/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.